General MedicationsORALStandard

CEPHALEXIN

Standard Dose

EQ 333MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview CEPHALEXIN is listed in Drugs@FDA under application 090836 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CEPHALEXIN Form and strength CAPSULE;ORAL - EQ 333MG BASE Sponsor ALKEM LABS LTD Submission history Latest submission status date: 2016-10-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEPHALEXIN is listed in Drugs@FDA under application 090836 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CEPHALEXIN Form and strength CAPSULE;ORAL - EQ 333MG BASE Sponsor ALKEM LABS LTD Submission history Latest submission status date: 2016-10-10 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.